Saladax Biomedical develops MyCare™ diagnostic tests for the practical delivery of personalized medicine and companion diagnostics. With MyCare tests, physicians can objectively assess whether patients are receiving the optimal dose of their prescribed medications in order to increase efficacy and reduce toxicity. 
We also work with pharmaceutical companies to develop companion diagnostics (CDx) to achieve optimal patient benefit for drugs in the development pipeline.
Saladax products are built upon the Company's validated MyCare technology platform and address a variety of therapeutic areas, with an initial focus in oncology. Our first test, My5-FU, measures levels of a common critical drug, 5-fluorouracil, in the blood of colorectal cancer patients.
To learn more, view this short video or download relevant studies.